Abstract
Hallucinations are severe and disabling symptoms experienced in various neurodegenerative and psychiatric conditions. Over the years, neuroimaging techniques have allowed the investigation of the neural mechanisms underpinning this symptomatology. The present chapter summarises positron emission tomography and single-photon emission computed tomography studies of hallucinations in patients with neurodegenerative and psychiatric disorders. The majority of these studies focused on visual hallucinations (VH) in Lewy body disease (LBD) and auditory verbal hallucinations (AVH) in schizophrenia, given their clinical relevance and high prevalence in these conditions. Impairments in bottom-up and top-down mechanisms appeared to be involved. Dysfunctions in brain areas implicated in sensory processing have been found in regions consistent with the hallucination sensory modality, especially in occipito-temporal areas in LBD with VH, and in primary and associative auditory cortices in schizophrenia with AVH, as well as in language-related regions in the latter. Top-down control mechanisms may also play a role that may be linked to impaired activity in frontoparietal areas in LBD and in the anterior cingulate cortex in schizophrenia. These findings suggest that similar mechanisms may underlie different types of hallucinations across diagnoses. Top-down control mechanisms over sensory pathways might foster the genesis and emergence of these symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aarsland D, Ballard C, Larsen JP, Mckeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16:528–536
Aarsland D, Marsh L, Schrag A (2009) Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord 24:2175–2186
Alderson-Day B, Diederen K, Fernyhough C, Ford JM, Horga G, Margulies DS, Mccarthy-Jones S, Northoff G, Shine JM, Turner J, van de Ven V, van Lutterveld R, Waters F, Jardri R (2016) Auditory hallucinations and the brain’s resting-state networks: findings and methodological observations. Schizophr Bull 42:1110–1123
Allen P, Aleman A, Mcguire PK (2007) Inner speech models of auditory verbal hallucinations: evidence from behavioural and neuroimaging studies. Int Rev Psychiatry 19:407–415
Allen P, Laroi F, Mcguire PK, Aleman A (2008) The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev 32:175–191
Allen P, Modinos G, Hubl D, Shields G, Cachia A, Jardri R, Thomas P, Woodward T, Shotbolt P, Plaze M, Hoffman R (2012) Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond. Schizophr Bull 38:695–703
Artiges E, Leroy C, Dubol M, Prat M, Pepin A, Mabondo A, de Beaurepaire R, Beaufils B, Korwin JP, Galinowski A, D’albis MA, Santiago-Ribeiro MJ, Granger B, Tzavara ET, Martinot JL, Trichard C (2017) Striatal and extrastriatal dopamine transporter availability in schizophrenia and its clinical correlates: a voxel-based and high-resolution PET study. Schizophr Bull 43:1134–1142
Ballanger B, Strafella AP, Van Eimeren T, Zurowski M, Rusjan PM, Houle S, Fox SH (2010) Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 67:416–421
Barnes J, Boubert L (2008) Executive functions are impaired in patients with Parkinson’s disease with visual hallucinations. J Neurol Neurosurg Psychiatry 79:190–192
Barnes J, Boubert L, Harris J, Lee A, David AS (2003) Reality monitoring and visual hallucinations in Parkinson’s disease. Neuropsychologia 41:565–574
Bassiony MM, Lyketsos CG (2003) Delusions and hallucinations in Alzheimer’s disease: review of the brain decade. Psychosomatics 44:388–401
Bejr-Kasem H, Pagonabarraga J, Martinez-Horta S, Sampedro F, Marin-Lahoz J, Horta-Barba A, Aracil-Bolanos I, Perez-Perez J, Angeles Boti M, Campolongo A, Izquierdo C, Pascual-Sedano B, Gomez-Anson B, Kulisevsky J (2019) Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson’s disease. Mov Disord 34:78–86
Blanc F, Noblet V, Philippi N, Cretin B, Foucher J, Armspach JP, Rousseau F (2014) Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases. PLoS One 9:e114774
Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P (2007) Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol 64:984–988
Braun CM, Dumont M, Duval J, Hamel-Hebert I, Godbout L (2003) Brain modules of hallucination: an analysis of multiple patients with brain lesions. J Psychiatry Neurosci 28:432–449
Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain’s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124:1–38
Cagnin A, Gnoato F, Jelcic N, Favaretto S, Zarantonello G, Ermani M, Dam M (2013) Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 84:505–510
Cassidy CM, Balsam PD, Weinstein JJ, Rosengard RJ, Slifstein M, Daw ND, Abi-Dargham A, Horga G (2018) A perceptual inference mechanism for hallucinations linked to striatal dopamine. Curr Biol 28:503–514.e4
Catani M, Thiebaut De Schotten M (2008) A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex 44:1105–1132
Cleghorn JM, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman H, Szechtman B, Franco S, Dermer SW, Cook P (1990) Regional brain metabolism during auditory hallucinations in chronic schizophrenia. Br J Psychiatry 157:562–570
Cleghorn JM, Franco S, Szechtman B, Kaplan RD, Szechtman H, Brown GM, Nahmias C, Garnett ES (1992) Toward a brain map of auditory hallucinations. Am J Psychiatry 149:1062–1069
Collerton D, Perry E, Mckeith I (2005) Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 28:737–757; discussion 757–94
Copolov DL, Seal ML, Maruff P, Ulusoy R, Wong MT, Tochon-Danguy HJ, Egan GF (2003) Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res 122:139–152
Damoiseaux JS, Rombouts SA, Barkhof F, Scheltens P, Stam CJ, Smith SM, Beckmann CF (2006) Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A 103:13848–13853
Dicarlo JJ, Zoccolan D, Rust NC (2012) How does the brain solve visual object recognition? Neuron 73:415–434
Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, HARDY J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8:1150–1157
El Haj M, Roche J, Jardri R, Kapogiannis D, Gallouj K, Antoine P (2017) Clinical and neurocognitive aspects of hallucinations in Alzheimer’s disease. Neurosci Biobehav Rev 83:713–720
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, Mckeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707; quiz 1837
Ffytche DH, Howard RJ, Brammer MJ, David A, Woodruff P, Williams S (1998) The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci 1:738–742
ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81–95
Firbank MJ, Lloyd J, O’brien JT (2016) The relationship between hallucinations and FDG-PET in dementia with Lewy bodies. Brain Imaging Behav 10:636–639
Franciotti R, Delli Pizzi S, Perfetti B, Tartaro A, Bonanni L, Thomas A, Weis L, Biundo R, Antonini A, Onofrj M (2015) Default mode network links to visual hallucinations: a comparison between Parkinson’s disease and multiple system atrophy. Mov Disord 30:1237–1247
Fusar-Poli P, Meyer-Lindenberg A (2013) Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. Schizophr Bull 39:33–42
Gallagher DA, Parkkinen L, O’sullivan SS, Spratt A, Shah A, Davey CC, Bremner FD, Revesz T, Williams DR, Lees AJ, Schrag A (2011) Testing an aetiological model of visual hallucinations in Parkinson’s disease. Brain 134:3299–3309
Gasca-Salas C, Clavero P, Garcia-Garcia D, Obeso JA, Rodriguez-Oroz MC (2016) Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson’s disease patients with mild cognitive impairment. Hum Brain Mapp 37:968–977
Gazzaley A, Nobre AC (2012) Top-down modulation: bridging selective attention and working memory. Trends Cogn Sci 16:129–135
Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, Detoledo-Morrell L, Goetz CG (2014) Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson’s disease with hallucinations. Brain 137:849–859
Gordon E, Barry RJ, Anderson J, Fawdry R, Yong C, Grunewald S, Meares RA (1994) Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia. Aust N Z J Psychiatry 28:446–452
Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258
Grossi D, Trojano L, Pellecchia MT, Amboni M, Fragassi NA, Barone P (2005) Frontal dysfunction contributes to the genesis of hallucinations in non-demented parkinsonian patients. Int J Geriatr Psychiatry 20:668–673
Gur RE, Mozley PD, Resnick SM, Mozley LH, Shtasel DL, Gallacher F, Arnold SE, Karp JS, Alavi A, Reivich M et al (1995) Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gen Psychiatry 52:657–667
Harding AJ, Broe GA, Halliday GM (2002a) Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125:391–403
Harding AJ, Stimson E, Henderson JM, halliday GM (2002b) Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain 125:2431–2445
Heitz C, Noblet V, Cretin B, Philippi N, Kremer L, Stackfleth M, Hubele F, Armspach JP, Namer I, Blanc F (2015) Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimers Res Ther 7:6
Hepp DH, Da Hora CC, Koene T, Uitdehaag BM, van den Heuvel OA, Klein M, van de Berg WD, Berendse HW, Foncke EM (2013) Cognitive correlates of visual hallucinations in non-demented Parkinson’s disease patients. Parkinsonism Relat Disord 19:795–799
Holroyd S, Wooten GF (2006) Preliminary FMRI evidence of visual system dysfunction in Parkinson’s disease patients with visual hallucinations. J Neuropsychiatry Clin Neurosci 18:402–404
Horacek J, Brunovsky M, Novak T, Skrdlantova L, Klirova M, Bubenikova-Valesova V, Krajca V, Tislerova B, Kopecek M, Spaniel F, Mohr P, Hoschl C (2007) Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations. Neuropsychobiology 55:132–142
Horga G, Parellada E, Lomena F, Fernandez-Egea E, Mane A, Font M, Falcon C, Konova AB, Pavia J, Ros D, Bernardo M (2011) Differential brain glucose metabolic patterns in antipsychotic-naive first-episode schizophrenia with and without auditory verbal hallucinations. J Psychiatry Neurosci 36:312–321
Howes OD, Egerton A, Allan V, Mcguire P, Stokes P, Kapur S (2009) Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des 15:2550–2559
Hugdahl K (2017) Auditory hallucinations as translational psychiatry: evidence from magnetic resonance imaging. Balkan Med J 34:504–513
Iaccarino L, Sala A, Caminiti SP, Santangelo R, Iannaccone S, Magnani G, Perani D (2018) The brain metabolic signature of visual hallucinations in dementia with Lewy bodies. Cortex 108:13–24
Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N, Juanes S, Tolosa E (2010) Differential progression of brain atrophy in Parkinson’s disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 81:650–657
Iizuka T, Kameyama M (2016) Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies. Ann Nucl Med 30:421–429
Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, Hanihara T, Sasaki M, Mori E (1999) Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 10:1903–1907
Imamura K, Wada-Isoe K, Kitayama M, Nakashima K (2008) Executive dysfunction in non-demented Parkinson’s disease patients with hallucinations. Acta Neurol Scand 117:255–259
Jaakkola E, Joutsa J, Makinen E, Johansson J, Kaasinen V (2017) Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson’s disease. Eur J Neurol 24:1341–1347
Jardri R, Pouchet A, Pins D, Thomas P (2011) Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry 168:73–81
Jellinger KA (2012) Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord 27:8–30
Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM (2009) Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord 15:196–204
Kalcher K, Huf W, Boubela RN, Filzmoser P, Pezawas L, Biswal B, Kasper S, Moser E, Windischberger C (2012) Fully exploratory network independent component analysis of the 1000 functional connectomes database. Front Hum Neurosci 6:301
Kantarci K, Avula R, Senjem ML, Samikoglu AR, Zhang B, Weigand SD, Przybelski SA, Edmonson HA, Vemuri P, Knopman DS, Ferman TJ, Boeve BF, Petersen RC, Jack CR Jr (2010) Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 74:1814–1821
Kantarci K, Lowe VJ, Boeve BF, Weigand SD, Senjem ML, Przybelski SA, Dickson DW, Parisi JE, Knopman DS, Smith GE, Ferman TJ, Petersen RC, Jack CR Jr (2012) Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging 33:2091–2105
Kataoka H, Furiya Y, Morikawa M, Ueno S, Inoue M (2008) Increased temporal blood flow associated with visual hallucinations in Parkinson’s disease with dementia. Mov Disord 23:464–465
Kazui H, Ishii R, Yoshida T, Ikezawa K, Takaya M, Tokunaga H, Tanaka T, Takeda M (2009) Neuroimaging studies in patients with Charles bonnet syndrome. Psychogeriatrics 9:77–84
Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213
Kiferle L, Ceravolo R, Giuntini M, Linsalata G, Puccini G, Volterrani D, Bonuccelli U (2014) Caudate dopaminergic denervation and visual hallucinations: evidence from a (1)(2)(3)I-FP-CIT SPECT study. Parkinsonism Relat Disord 20:761–765
Kim JH, Son YD, Lee HJ, Kang NI, Chung GH, Park JI, Cui Y, Kim WS, Chung YC (2018) Neural signature for auditory hallucinations in schizophrenia: a high-resolution positron emission tomography study with fludeoxyglucose ((18)F). Clin Psychopharmacol Neurosci 16:324–332
Klirova M, Horacek J, Novak T, Cermak J, Spaniel F, Skrdlantova L, Mohr P, Hoschl C (2013) Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study. Eur Arch Psychiatry Clin Neurosci 263:475–484
Koerts J, Borg MA, Meppelink AM, Leenders KL, van Beilen M, van Laar T (2010) Attentional and perceptual impairments in Parkinson’s disease with visual hallucinations. Parkinsonism Relat Disord 16:270–274
Kopecek M, Spaniel F, Novak T, Tislerova B, Belohlavek O, Horacek J (2007) 18FDG PET in hallucinating and non-hallucinating patients. Neuro Endocrinol Lett 28:53–59
Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R (1995) SPECT findings on psychosis in Alzheimer’s disease. Am J Psychiatry 152:1470–1475
Kravitz DJ, Saleem KS, Baker CI, Ungerleider LG, Mishkin M (2013) The ventral visual pathway: an expanded neural framework for the processing of object quality. Trends Cogn Sci 17:26–49
Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R (2006) Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology 31:221–230
Lefebvre S, Baille G, Jardri R, Plomhause L, Szaffarczyk S, Defebvre L, Thomas P, Delmaire C, Pins D, Dujardin K (2016) Hallucinations and conscious access to visual inputs in Parkinson’s disease. Sci Rep 6:36,284
Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2003) Cognitive impairments in early Parkinson’s disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23:6351–6356
Linszen MMJ, Lemstra AW, Dauwan M, Brouwer RM, Scheltens P, Sommer IEC (2018) Understanding hallucinations in probable Alzheimer’s disease: very low prevalence rates in a tertiary memory clinic. Alzheimers Dement (Amst) 10:358–362
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812–819
Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O’brien JT (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56:643–649
Lopez OL, Smith G, Becker JT, Meltzer CC, Dekosky ST (2001) The psychotic phenomenon in probable Alzheimer’s disease: a positron emission tomography study. J Neuropsychiatry Clin Neurosci 13:50–55
Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F (2006a) Hypoperfusion of the auditory and prefrontal cortices in parkinsonian patients with verbal hallucinations. Mov Disord 21:2165–2169
Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F (2006b) Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations. Mov Disord 21:2140–2144
Matsui H, Nishinaka K, Miyoshi T, Hara N, Oda M, Kubori T, Udaka F (2007) Thalamic hyperperfusion in verbal hallucination of parkinsonian patients. Intern Med 46:1765–1769
McGuire PK, Shah GM, Murray RM (1993) Increased blood flow in Broca’s area during auditory hallucinations in schizophrenia. Lancet 342:703–706
McGuire PK, Silbersweig DA, Wright I, Murray RM, Frackowiak RS, Frith CD (1996) The neural correlates of inner speech and auditory verbal imagery in schizophrenia: relationship to auditory verbal hallucinations. Br J Psychiatry 169:148–159
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88–100
Mechelli A, Allen P, Amaro E Jr, Fu CH, Williams SC, Brammer MJ, Johns LC, McGuire PK (2007) Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations. Hum Brain Mapp 28:1213–1222
Menon V (2011) Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci 15:483–506
Menon V, Uddin LQ (2010) Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214:655–667
Modinos G, Costafreda SG, Van Tol MJ, McGuire PK, Aleman A, Allen P (2013) Neuroanatomy of auditory verbal hallucinations in schizophrenia: a quantitative meta-analysis of voxel-based morphometry studies. Cortex 49:1046–1055
Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, Van Der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F (2019) Metabolic patterns across core features in dementia with Lewy bodies (DLB). Ann Neurol 85:715
Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, Tanimukai S, Kazui H, Hanihara T (2000) Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 57:489–493
Mori T, Ikeda M, Fukuhara R, Sugawara Y, Nakata S, Matsumoto N, Nestor PJ, Tanabe H (2006) Regional cerebral blood flow change in a case of Alzheimer’s disease with musical hallucinations. Eur Arch Psychiatry Clin Neurosci 256:236–239
Mosimann UP, Mather G, Wesnes KA, O’brien JT, Burn DJ, McKeith IG (2004) Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 63:2091–2096
Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA (2014) Psychosis in Alzheimer’s disease. Biol Psychiatry 75:542–552
Musalek M, Podreka I, Suess E, Nutzinger D, Passweg V, Strobl R, Walter H, Baumgartner C, Lesch OM (1988) Neurophysiological aspects of auditory hallucinations. 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls—a preliminary report. Psychopathology 21:275–280
Musalek M, Podreka I, Walter H, Suess E, Passweg V, Nutzinger D, Strobl R, Lesch OM (1989) Regional brain function in hallucinations: a study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls. Compr Psychiatry 30:99–108
Nagahama Y, Okina T, Suzuki N, Matsuda M (2010) Neural correlates of psychotic symptoms in dementia with Lewy bodies. Brain 133:557–567
Nagano-Saito A, Washimi Y, Arahata Y, Iwai K, Kawatsu S, Ito K, Nakamura A, Abe Y, Yamada T, Kato T, Kachi T (2004) Visual hallucination in Parkinson’s disease with FDG PET. Mov Disord 19:801–806
Nicastro N, Eger AF, Assal F, Garibotto V (2018) Feeling of presence in dementia with Lewy bodies is related to reduced left frontoparietal metabolism. Brain Imaging Behav 14:1199–1207
Nishio Y, Yokoi K, Uchiyama M, Mamiya Y, Watanabe H, Gang M, Baba T, Takeda A, Hirayama K, Mori E (2017) Deconstructing psychosis and misperception symptoms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 88:722–729
Nishio Y, Yokoi K, Hirayama K, Ishioka T, Hosokai Y, Gang M, Uchiyama M, Baba T, Suzuki K, Takeda A, Mori E (2018) Defining visual illusions in Parkinson’s disease: Kinetopsia and object misidentification illusions. Parkinsonism Relat Disord 55:111–116
Nobre AC, Mesulam MM (2014) Large-scale networks for attentional biases. In: Nobre AC, Kastner S (eds) The Oxford handbook of attention. Oxford University Press, Oxford, UK
Notardonato H, Gonzalez-Avilez A, Van Heertum RL, O’connell RA, Yudd AP (1989) The potential value of serial cerebral SPECT scanning in the evaluation of psychiatric illness. Clin Nucl Med 14:319–322
O’brien JT, Firbank MJ, Mosimann UP, Burn DJ, Mckeith IG (2005) Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res 139:79–88
Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H (2005) Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 65:1708–1715
Onofrj M, Thomas A, D’andreamatteo G, Iacono D, Luciano AL, Di Rollo A, Di Mascio R, Ballone E, Di Iorio A (2002) Incidence of RBD and hallucination in patients affected by Parkinson’s disease: 8-year follow-up. Neurol Sci 23(Suppl 2):S91–S94
Onofrj M, Taylor JP, Monaco D, Franciotti R, Anzellotti F, Bonanni L, Onofrj V, Thomas A (2013) Visual hallucinations in PD and Lewy body dementias: old and new hypotheses. Behav Neurol 27:479–493
Osaki Y, Morita Y, Fukumoto M, Akagi N, Yoshida S, Doi Y (2005) Three-dimensional stereotactic surface projection SPECT analysis in Parkinson’s disease with and without dementia. Mov Disord 20:999–1005
Ozer F, Meral H, Hanoglu L, Ozturk O, Aydemir T, Cetin S, Atmaca B, Tiras R (2007) Cognitive impairment patterns in Parkinson’s disease with visual hallucinations. J Clin Neurosci 14:742–746
Papapetropoulos S, Mccorquodale DS, Gonzalez J, Jean-Gilles L, Mash DC (2006) Cortical and amygdalar Lewy body burden in Parkinson’s disease patients with visual hallucinations. Parkinsonism Relat Disord 12:253–256
Parellada E, Lomena F, Font M, Pareto D, Gutierrez F, Simo M, Fernandez-Egea E, Pavia J, Ros D, Bernardo M (2008) Fluorodeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation. Nucl Med Commun 29:894–900
Park HK, Kim JS, Im KC, Kim MJ, Lee JH, Lee MC, Kim J, Chung SJ (2013) Visual hallucinations and cognitive impairment in Parkinson’s disease. Can J Neurol Sci 40:657–662
Pasquier J, Michel BF, Brenot-Rossi I, Hassan-Sebbag N, Sauvan R, Gastaut JL (2002) Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 29:1342–1348
Perneczky R, Drzezga A, Boecker H, Forstl H, Kurz A, Haussermann P (2008) Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 25:531–538
Pezzoli S, Cagnin A, Bandmann O, Venneri A (2017) Structural and functional neuroimaging of visual hallucinations in Lewy body disease: a systematic literature review. Brain Sci 7:84
Pezzoli S, Cagnin A, Antonini A, Venneri A (2019) Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease. Postgrad Med 131:1–14
Raichle ME (2015) The brain’s default mode network. Annu Rev Neurosci 38:433–447
Raichle ME, Macleod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci U S A 98:676
Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Tolosa E (2006) Neuropsychological deficits in Parkinson’s disease patients with visual hallucinations. Mov Disord 21:1483–1487
Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Tolosa E (2007a) Cognitive changes in Parkinson’s disease patients with visual hallucinations. Dement Geriatr Cogn Disord 23:281–288
Ramirez-Ruiz B, Marti MJ, Tolosa E, Gimenez M, Bargallo N, Valldeoriola F, Junque C (2007b) Cerebral atrophy in Parkinson’s disease patients with visual hallucinations. Eur J Neurol 14:750–756
Rosazza C, Minati L (2011) Resting-state brain networks: literature review and clinical applications. Neurol Sci 32:773–785
Rosazza C, Minati L, Ghielmetti F, Mandelli ML, Bruzzone MG (2012) Functional connectivity during resting-state functional MR imaging: study of the correspondence between independent component analysis and region-of-interest-based methods. AJNR Am J Neuroradiol 33:180–187
Roselli F, Pisciotta NM, Perneczky R, Pennelli M, Aniello MS, De Caro MF, Ferrannini E, Tartaglione B, Defazio G, Rubini G, Livrea P (2009) Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Mov Disord 24:2097–2103
Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U (1997) Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 349:1735–1739
Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C (2010) Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease with dementia. Mov Disord 25:615–622
Santangelo G, Trojano L, Vitale C, Ianniciello M, Amboni M, Grossi D, Barone P (2007) A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations. Mov Disord 22:2418–2425
Shergill SS, Bullmore E, Simmons A, Murray R, McGuire P (2000) Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. Am J Psychiatry 157:1691–1693
Shergill SS, Brammer MJ, Fukuda R, Williams SC, Murray RM, McGuire PK (2003) Engagement of brain areas implicated in processing inner speech in people with auditory hallucinations. Br J Psychiatry 182:525–531
Shine JM, Halliday GM, Naismith SL, Lewis SJ (2011) Visual misperceptions and hallucinations in Parkinson’s disease: dysfunction of attentional control networks? Mov Disord 26:2154–2159
Shine JM, Halliday GM, Gilat M, Matar E, Bolitho SJ, Carlos M, Naismith SL, Lewis SJ (2014a) The role of dysfunctional attentional control networks in visual misperceptions in Parkinson’s disease. Hum Brain Mapp 35:2206–2219
Shine JM, O’callaghan C, Halliday GM, Lewis SJ (2014b) Tricks of the mind: visual hallucinations as disorders of attention. Prog Neurobiol 116:58–65
Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L et al (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature 378:176–179
Sporns O (2013) Structure and function of complex brain networks. Dialogues Clin Neurosci 15:247–262
Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, Gabrieli JD (2004) Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 63:1409–1416
Stephane M, Hagen MC, Lee JT, Uecker J, Pardo PJ, Kuskowski MA, Pardo JV (2006) About the mechanisms of auditory verbal hallucinations: a positron emission tomographic study. J Psychiatry Neurosci 31:396–405
Suzuki M, Yuasa S, Minabe Y, Murata M, Kurachi M (1993) Left superior temporal blood flow increases in schizophrenic and schizophreniform patients with auditory hallucination: a longitudinal case study using 123I-IMP SPECT. Eur Arch Psychiatry Clin Neurosci 242:257–261
Tiraboschi P, Salmon DP, Hansen LA, Hofstetter RC, Thal LJ, Corey-Bloom J (2006) What best differentiates Lewy body from Alzheimer’s disease in early-stage dementia? Brain 129:729–735
Tracy DK, Shergill SS (2013) Mechanisms underlying auditory hallucinations-understanding perception without stimulus. Brain Sci 3:642–669
Uchiyama M, Nishio Y, Yokoi K, Hosokai Y, Takeda A, Mori E (2015) Pareidolia in Parkinson’s disease without dementia: A positron emission tomography study. Parkinsonism Relat Disord 21:603–609
Utevsky AV, Smith DV, Huettel SA (2014) Precuneus is a functional core of the default-mode network. J Neurosci 34:932–940
Watanabe H, Senda J, Kato S, Ito M, Atsuta N, Hara K, Tsuboi T, Katsuno M, Nakamura T, Hirayama M, Adachi H, Naganawa S, Sobue G (2013) Cortical and subcortical brain atrophy in Parkinson’s disease with visual hallucination. Mov Disord 28:1732–1736
Waters F, Allen P, Aleman A, Fernyhough C, Woodward TS, Badcock JC, Barkus E, Johns L, Varese F, Menon M, Vercammen A, Laroi F (2012) Auditory hallucinations in schizophrenia and nonschizophrenia populations: a review and integrated model of cognitive mechanisms. Schizophr Bull 38:683–693
Waters F, Collerton D, Ffytche DH, Jardri R, Pins D, Dudley R, Blom JD, Mosimann UP, Eperjesi F, Ford S, Laroi F (2014) Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull 40(Suppl 4):S233–S245
Williams DR, Lees AJ (2005) Visual hallucinations in the diagnosis of idiopathic Parkinson’s disease: a retrospective autopsy study. Lancet Neurol 4:605–610
Yao N, Shek-Kwan CR, Cheung C, Pang S, Lau KK, Suckling J, ROWE JB, Yu K, Ka-Fung Mak H, Chua SE, Ho SL, McAlonan GM (2014) The default mode network is disrupted in Parkinson’s disease with visual hallucinations. Hum Brain Mapp 35:5658–5666
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pezzoli, S., Venneri, A. (2021). Neuroimaging Findings in Patients with Hallucinations: Evidence from Neurodegenerative and Psychiatric Conditions. In: Dierckx, R.A., Otte, A., de Vries, E.F.J., van Waarde, A., Sommer, I.E. (eds) PET and SPECT in Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-57231-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-57231-0_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57230-3
Online ISBN: 978-3-030-57231-0
eBook Packages: MedicineMedicine (R0)